{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:18:55Z","timestamp":1707524335286},"reference-count":13,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,6,28]]},"DOI":"10.7759\/cureus.16001","type":"journal-article","created":{"date-parts":[[2021,6,28]],"date-time":"2021-06-28T22:08:17Z","timestamp":1624918097000},"source":"Crossref","is-referenced-by-count":2,"title":["A Case of Statin-Associated Immune-Mediated Necrotizing Myopathy, Successfully Treated With Intravenous Immunoglobulin"],"prefix":"10.7759","author":[{"given":"Mishouri","family":"Paul","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Prodip","family":"Paul","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dipon","family":"Dey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Syed W","family":"Moazzem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fariya","family":"Shamrin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.165.22.2671","article-title":"Outcomes in 45 patients with statin-associated myopathy","volume":"165","author":"Hansen KE","year":"2005","unstructured":"Hansen KE, Hildebrand JP, Ferguson EE, Stein JH. Outcomes in 45 patients with statin-associated myopathy. Arch Intern Med. 2005, 165:2671-2676. 10.1001\/archinte.165.22.2671","journal-title":"Arch Intern Med"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacl.2012.03.003","article-title":"Understanding statin use in America and gaps in patient education (USAGE): an internet-based survey of 10,138 current and former statin users","volume":"6","author":"Cohen JD","year":"2012","unstructured":"Cohen JD, Brinton EA, Ito MK, Jacobson TA. Understanding statin use in America and gaps in patient education (USAGE): an internet-based survey of 10,138 current and former statin users. J Clin Lipidol. 2012, 6:208-215. 10.1016\/j.jacl.2012.03.003","journal-title":"J Clin Lipidol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1007\/s10557-005-5686-z","article-title":"Mild to moderate muscular symptoms with high-dosage statin therapy in hyperlipidemic patients--the PRIMO study","volume":"19","author":"Bruckert E","year":"2005","unstructured":"Bruckert E, Hayem G, Dejager S, Yau C, B\u00e9gaud B. Mild to moderate muscular symptoms with high-dosage statin therapy in hyperlipidemic patients--the PRIMO study. Cardiovasc Drugs Ther. 2005, 19:403-414. 10.1007\/s10557-005-5686-z","journal-title":"Cardiovasc Drugs Ther"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(18)30254-0","article-title":"Classification and management of adult inflammatory myopathies","volume":"17","author":"Selva-O'Callaghan A","year":"2018","unstructured":"Selva-O'Callaghan A, Pinal-Fernandez I, Trallero-Aragu\u00e1s E, Milisenda JC, Grau-Junyent JM, Mammen AL\r\n. Classification and management of adult inflammatory myopathies. Lancet Neurology. 2018, 17:816-828. 10.1016\/S1474-4422(18)30254-0","journal-title":"Lancet Neurology"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosis.2011.11.005","article-title":"Statins as a possible cause of inflammatory and necrotizing myopathies","volume":"222","author":"Padala S","year":"2012","unstructured":"Padala S, Thompson PD. Statins as a possible cause of inflammatory and necrotizing myopathies. Atherosclerosis. 2012, 222:15-21. 10.1016\/j.atherosclerosis.2011.11.005","journal-title":"Atherosclerosis"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1002\/mus.21486","article-title":"Immune-mediated necrotizing myopathy associated with statins","volume":"41","author":"Grable-Esposito P","year":"2010","unstructured":"Grable-Esposito P, Katzberg HD, Greenberg SA, Srinivasan J, Katz J, Amato AA. Immune-mediated necrotizing myopathy associated with statins. Muscle Nerve. 2010, 41:185-190. 10.1002\/mus.21486","journal-title":"Muscle Nerve"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1515161","article-title":"Statin-associated autoimmune myopathy","volume":"374","author":"Mammen AL","year":"2016","unstructured":"Mammen AL. Statin-associated autoimmune myopathy. N Engl J Med. 2016, 374:664-669. 10.1056\/NEJMra1515161","journal-title":"N Engl J Med"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1007\/s11940-011-0119-8","article-title":"Immunotherapy of inflammatory myopathies: practical approach and future prospects","volume":"13","author":"Dalakas MC","year":"2011","unstructured":"Dalakas MC. Immunotherapy of inflammatory myopathies: practical approach and future prospects. Curr Treat Options Neurol. 2011, 13:311-323. 10.1007\/s11940-011-0119-8","journal-title":"Curr Treat Options Neurol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0141616","article-title":"Clinical characteristics of anti-3-hydroxy-3-methylglutaryl coenzyme A reductase antibodies in Chinese patients with idiopathic inflammatory myopathies","volume":"10","author":"Ge Y","year":"2015","unstructured":"Ge Y, Lu X, Peng Q, Shu X, Wang G. Clinical characteristics of anti-3-hydroxy-3-methylglutaryl coenzyme A reductase antibodies in Chinese patients with idiopathic inflammatory myopathies. PLoS One. 2015, 10:e0141616. 10.1371\/journal.pone.0141616","journal-title":"PLoS One"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1002\/art.30156","article-title":"Autoantibodies against 3-hydroxy-3-methylglutaryl-coenzyme A reductase in patients with statin-associated autoimmune myopathy","volume":"63","author":"Mammen AL","year":"2011","unstructured":"Mammen AL, Chung T, Christopher-Stine L, Rosen P, Rosen A, Doering KR, Casciola-Rosen LA. Autoantibodies against 3-hydroxy-3-methylglutaryl-coenzyme A reductase in patients with statin-associated autoimmune myopathy. Arthritis Rheum. 2011, 63:713-721. 10.1002\/art.30156","journal-title":"Arthritis Rheum"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.7963","article-title":"Statin-induced immune-mediated necrotizing myopathy: an increasingly recognized inflammatory myopathy","volume":"12","author":"Stroie OP","year":"2020","unstructured":"Stroie OP, Boster J, Surry L. Statin-induced immune-mediated necrotizing myopathy: an increasingly recognized inflammatory myopathy. Cureus. 2020, 12:e7963. 10.7759\/cureus.7963","journal-title":"Cureus"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1007\/s13311-015-0394-2","article-title":"Immunotherapies for immune-mediated myopathies: a current perspective","volume":"13","author":"Needham M","year":"2016","unstructured":"Needham M, Mastaglia FL. Immunotherapies for immune-mediated myopathies: a current perspective. Neurotherapeutics. 2016, 13:132-146. 10.1007\/s13311-015-0394-2","journal-title":"Neurotherapeutics"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc1506163","article-title":"Intravenous immune globulin for statin-triggered autoimmune myopathy","volume":"373","author":"Mammen AL","year":"2015","unstructured":"Mammen AL, Tiniakou E. Intravenous immune globulin for statin-triggered autoimmune myopathy. N Engl J Med. 2015, 373:1680-1682. 10.1056\/NEJMc1506163","journal-title":"N Engl J Med"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/60584-a-case-of-statin-associated-immune-mediated-necrotizing-myopathy-successfully-treated-with-intravenous-immunoglobulin","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:31:57Z","timestamp":1707507117000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/60584-a-case-of-statin-associated-immune-mediated-necrotizing-myopathy-successfully-treated-with-intravenous-immunoglobulin"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,28]]},"references-count":13,"URL":"https:\/\/doi.org\/10.7759\/cureus.16001","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2021,6,28]]}}}